Coastlands Capital LP's Form 4 filing
Bolt Biotherapeutics, Inc.BOLT · filed Nov 17, 2026
- Accession no.
- 0001104659-26-129252
- Filed
- Nov 17, 2026, 8:42 PM ET
- Trade date
- Nov 16-17, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $309.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coastlands Capital LPCIK 0002068530 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | PPurchaseAcquired | +33,094 | $5.89F1 | +$194,923.66 | 495,510 | Indirect | |
| Nov 17, 2026 | Common Stock | PPurchaseAcquired | +20,000 | $5.75 | +$114,998 | 515,510 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $5.8000 to $5.9136. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.